AKT1 and retinoblastoma: Western blotting revealed that silencing PTEN significantly activated the AKT/mTOR pathway, suppressed CD24‐induced conversion of LC3‐I to LC3‐II, and simultaneously increased p62 protein expression in RB cells treated with VCR (Fig. 6C,D and Fig. S3B).